Sevelamer carbonate increases serum bicarbonate in pediatric dialysis patients

Pediatric Nephrology

Volumn 25, Issue 2, 2010, Pages 373-375

  Gonzalez, Elsa ^a   Schomberg, John ^a   Amin, Nimisha ^a   Salusky, Isidro B ^a   Zaritsky, Joshua ^a  

^a MATTEL CHILDREN S HOSPITAL   (United States)

Author keywords

Metabolic acidosis; Pediatric dialysis patients; Sevelamer carbonate; Sevelamer HCl

Indexed keywords

BICARBONATE; PARATHYROID HORMONE; PHOSPHATE BINDING AGENT; SEVELAMER; SEVELAMER CARBONATE; UNCLASSIFIED DRUG; VITAMIN D; CHELATING AGENT; HEMODIALYSIS FLUID; POLYAMINE;

ADOLESCENT; ARTICLE; BICARBONATE BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEMODIALYSIS; HUMAN; METABOLIC ACIDOSIS; PARATHYROID HORMONE BLOOD LEVEL; PERITONEAL DIALYSIS; PRIORITY JOURNAL; SODIUM INTAKE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; BLOOD; FEMALE; MALE; METHODOLOGY; PROSPECTIVE STUDY;

ADOLESCENT; CHELATING AGENTS; FEMALE; HEMODIALYSIS SOLUTIONS; HUMANS; MALE; PERITONEAL DIALYSIS; POLYAMINES; PROSPECTIVE STUDIES; SODIUM BICARBONATE;

EID: 77950474312     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-009-1328-1     Document Type: Article

References (18)

1. Foley RN, Parfrey PS, Sarnak MJ (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32:S112-S119 (Pubitemid 28527268)
2. Guerin AP, London GM, Marchais SJ, Metivier F (2000) Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 15:1014-1021 (Pubitemid 30410374)
3. Goodman WG,Goldin J,Kuizon BD,Yoon C, Gales B, Sider D,Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478-1483 (Pubitemid 30318271)
4. Mitsnefes MM, Daniels SR, Schwartz SM, Meyer RA, Khoury P, Strife CF (2000) Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr Nephrol 14:898-902 (Pubitemid 30621296)
5. Shroff RC, McNair R, Figg N, Skepper JN, Schurgers L, Gupta A, Hiorns M, Donald AE, Deanfield J, Rees L, Shanahan CM (2008) Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 118:1748-1757
6. Chertow GM, Burke SK, Raggi P (2002) Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62:245-252 (Pubitemid 34754068)
7. Mahdavi H, Kuizon BD, Gales B, Wang HJ, Elashoff RM, Salusky IB (2003) Sevelamer hydrochloride: an effective phosphate binder in dialyzed children. Pediatr Nephrol 18:1260-1264 (Pubitemid 37527101)
8. Salusky IB, Goodman WG, Sahney S, Gales B, Perilloux A, Wang HJ, Elashoff RM, Juppner H (2005) Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols. J Am Soc Nephrol 16:2501-2508 (Pubitemid 41725070)
9. Pieper AK, Haffner D, Hoppe B, Dittrich K, Offner G, Bonzel KE, John U, Frund S, Klaus G, Stubinger A, Duker G, Querfeld U (2006) A randomized crossover trial comparing sevelamer with calcium acetate in children with CKD. Am J Kidney Dis 47:625-635
10. Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A, Raggi P (2005) Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 68:1815-1824 (Pubitemid 43169927)
11. Oka Y, Miyazaki M, Takatsu S, Oohara T, Toda K, Uno F, Matsuda H (2008) A review article: sevelamer hydrochloride and metabolic acidosis in dialysis patients. Cardiovasc Hematol Disord Drug Targets 8:283-286
12. Delmez J, Block G, Robertson J, Chasan-Taber S, Blair A, Dillon M, Bleyer AJ (2007) A randomized, double-blind, crossover design study of sevelamer hydrochloride and sevelamer carbonate in patients on hemodialysis. Clin Nephrol 68:386-391 (Pubitemid 350258767)
13. Ketteler M, Rix M, Fan S, Pritchard N, Oestergaard O, Chasan- Taber S, Heaton J, Duggal A, Kalra PA (2008) Efficacy and tolerability of sevelamer carbonate in hyperphosphatemic patients who have chronic kidney disease and are not on dialysis. Clin J Am Soc Nephrol 3:1125-1130
14. Furth SL, Hwang W, Yang C, Neu AM, Fivush BA, Powe NR (2002) Growth failure, risk of hospitalization and death for children with end-stage renal disease. Pediatr Nephrol 17:450-455 (Pubitemid 36067995)
15. Kuizon BD, Salusky IB (1999) Growth retardation in children with chronic renal failure. J Bone Miner Res 14:1680-1690 (Pubitemid 29455816)
16. Kraut JA, Mishler DR, Singer FR, Goodman WG (1986) The effects of metabolic acidosis on bone formation and bone resorption in the rat. Kidney Int 30:694-700 (Pubitemid 17049587)
17. National Kidney Foundation (2009) KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 Update. Am J Kidney Dis 53(Suppl 2):S1-S124
18. Kayikcioglu M, Tumuklu M, Ozkahya M, Ozdogan O, Asci G, Duman S, Toz H, Can LH, Basci A, Ok E (2009) The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis. Nephrol Dial Transplant 24:956-962